Invention Grant
![Pyridino[1,2-A]pyrimidone analogue used as P13K inhibitor](/docs/US/2018-01-02/US09856256B2/abs.jpg.600x600.jpg)
- Patent Title: Pyridino[1,2-A]pyrimidone analogue used as P13K inhibitor
-
Application No.: US15319726Application Date: 2015-06-16
-
Publication No.: US09856256B2Publication Date: 2018-01-02
- Inventor: Chengde Wu , Tao Yu , Shuhui Chen
- Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
- Applicant Address: CN Lianyungang, Jiangsu
- Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
- Current Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
- Current Assignee Address: CN Lianyungang, Jiangsu
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Priority: CN201410271282 20140617; CN201510324348 20150612
- International Application: PCT/CN2015/081518 WO 20150616
- International Announcement: WO2015/192760 WO 20151223
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04 ; C07D491/147 ; C07D519/00
![Pyridino[1,2-A]pyrimidone analogue used as P13K inhibitor](/abs-image/US/2018/01/02/US09856256B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to novel pyridino[1,2-α]pyrimidone compounds represented by formula (I) or pharmaceutically acceptable salts thereof; and a method of use thereof for treating tumors, such as colon cancer and gastric cancer.
Public/Granted literature
- US20170137420A1 PYRIDINO[1,2-A]PYRIMIDONE ANALOGUE USED AS P13K INHIBITOR Public/Granted day:2017-05-18
Information query
